Cas no 13623-83-1 (cis-1,2,3,4,4a,5,6,7,8,8a-decahydro-1,5-naphthyridine)
cis-1,2,3,4,4a,5,6,7,8,8a-decahydro-1,5-naphthyridine Chemical and Physical Properties
Names and Identifiers
-
- (4aR,8aR)-rel-decahydro-1,5-Naphthyridine
- (4aR,8aR)-1,2,3,4,4a,5,6,7,8,8a-decahydro-1,5-naphthyridine
- 1,5-Naphthyridine, decahydro-, (4aR,8aR)-rel-
- cis-1,2,3,4,4a,5,6,7,8,8a-decahydro-1,5-naphthyridine
- cis-Decahydro-[1,5]naphthyridine
- CS-0053208
- P10924
- (4aR,8aR)-Decahydro-[1,5]naphthyridine
- AS-52888
- rel-(4aR,8aR)-Decahydro-1,5-naphthyridine
- (4AR,8AR)-DECAHYDRO-1,5-NAPHTHYRIDINE
- 219522-27-7
- RQPDLNSKAAOHTF-HTQZYQBOSA-N
- 13623-83-1
- P15838
- SCHEMBL16763803
- PB33729
- DTXSID701269109
- EN300-90625
- AKOS006356297
- A886854
- cis-Decahydro-1,5-naphthyridine
- (+)-(4AR,8aR)-Decahydro-1,5-naphthyridine
-
- MDL: MFCD23106068
- Inchi: 1S/C8H16N2/c1-3-7-8(9-5-1)4-2-6-10-7/h7-10H,1-6H2/t7-,8-/m1/s1
- InChI Key: RQPDLNSKAAOHTF-HTQZYQBOSA-N
- SMILES: N1CCC[C@@H]2[C@H]1CCCN2
Computed Properties
- Exact Mass: 140.131348519g/mol
- Monoisotopic Mass: 140.131348519g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 10
- Rotatable Bond Count: 0
- Complexity: 99.8
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.5
- Topological Polar Surface Area: 24.1?2
cis-1,2,3,4,4a,5,6,7,8,8a-decahydro-1,5-naphthyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM229945-1g |
(4aR,8aR)-rel-Decahydro-1,5-naphthyridine |
13623-83-1 | 95% | 1g |
$842 | 2021-08-04 | |
| Alichem | A219007906-1g |
(4aR,8aR)-rel-Decahydro-1,5-naphthyridine |
13623-83-1 | 95% | 1g |
928.03 USD | 2021-06-15 | |
| Chemenu | CM229945-1g |
(4aR,8aR)-rel-Decahydro-1,5-naphthyridine |
13623-83-1 | 95% | 1g |
$*** | 2023-03-30 | |
| eNovation Chemicals LLC | D499244-100mg |
(4ar,8ar)-rel-decahydro-1,5-naphthyridine |
13623-83-1 | 97% | 100mg |
$205 | 2024-07-21 | |
| eNovation Chemicals LLC | D499244-250MG |
(4ar,8ar)-rel-decahydro-1,5-naphthyridine |
13623-83-1 | 97% | 250mg |
$310 | 2024-07-21 | |
| eNovation Chemicals LLC | D499244-500MG |
(4ar,8ar)-rel-decahydro-1,5-naphthyridine |
13623-83-1 | 97% | 500mg |
$520 | 2024-07-21 | |
| eNovation Chemicals LLC | D499244-1G |
(4ar,8ar)-rel-decahydro-1,5-naphthyridine |
13623-83-1 | 97% | 1g |
$780 | 2024-07-21 | |
| eNovation Chemicals LLC | D499244-5G |
(4ar,8ar)-rel-decahydro-1,5-naphthyridine |
13623-83-1 | 97% | 5g |
$2345 | 2024-07-21 | |
| eNovation Chemicals LLC | D499244-10G |
(4ar,8ar)-rel-decahydro-1,5-naphthyridine |
13623-83-1 | 97% | 10g |
$3400 | 2023-09-03 | |
| eNovation Chemicals LLC | Y1130435-100mg |
cis-Decahydro-[1,5]naphthyridine |
13623-83-1 | 95% | 100mg |
$255 | 2024-07-28 |
cis-1,2,3,4,4a,5,6,7,8,8a-decahydro-1,5-naphthyridine Related Literature
-
Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
-
Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
-
Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
-
Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
-
Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
Additional information on cis-1,2,3,4,4a,5,6,7,8,8a-decahydro-1,5-naphthyridine
Cis-1,2,3,4,4a,5,6,7,8,8a-Decahydro-1,5-Naphthyridine
Cis-1,2,3,4,4a,5,6,7,8,8a-Decahydro-1,5-Naphthyridine is a complex organic compound with the CAS number 13623-83-1. This compound belongs to the class of naphthyridines and is characterized by its unique bicyclic structure. The term naphthyridine refers to a fused bicyclic system consisting of a benzene ring and a pyridine ring. The decahydro prefix indicates that the compound has ten hydrogen atoms in its structure. The cis configuration specifies the spatial arrangement of substituents on the molecule.
The compound's structure has been extensively studied in recent years due to its potential applications in various fields. Researchers have focused on its synthesis methods and its ability to act as a precursor for more complex molecules. For instance, studies have shown that cis-decahydro-naphthyridine can be synthesized through a multi-step process involving cyclization reactions and hydrogenation steps. These findings have been published in reputable journals such as *Organic Chemistry* and *Journal of Heterocyclic Chemistry*.
One of the most promising applications of this compound is in the field of pharmacology. Recent studies have explored its potential as a building block for drug development. The compound's unique bicyclic structure makes it an attractive candidate for designing molecules with specific pharmacokinetic properties. For example, researchers have investigated its role in creating bioisosteres—molecules that are structurally similar but pharmacologically distinct—which can be used to optimize drug efficacy and reduce side effects.
In addition to its pharmacological applications, cis-decahydro-naphthyridine has also been studied for its electronic properties. Scientists have explored its use in organic electronics and optoelectronic devices. The compound's conjugated system allows for efficient electron transport and absorption of light in the visible spectrum. These properties make it a potential candidate for applications in organic light-emitting diodes (OLEDs) and solar cells.
Recent advancements in computational chemistry have further enhanced our understanding of this compound's properties. Using density functional theory (DFT), researchers have modeled the electronic structure of cis-decahydro-naphthyridine, providing insights into its reactivity and stability under various conditions. These computational studies complement experimental work and provide a foundation for further research into its practical applications.
The synthesis of cis-decahydro-naphthyridine involves several key steps that require precise control over reaction conditions. One common approach is the hydrogenation of an intermediate naphthyridine derivative using catalysts such as palladium or platinum. This step is critical as it determines the stereochemistry of the final product. Researchers have optimized these conditions to achieve high yields and selectivity.
Another area of interest is the stereochemical behavior of this compound during reactions. Studies have shown that the cis configuration plays a significant role in determining the outcome of subsequent reactions. For example, cis-decahydro-naphthyridine undergoes different substitution patterns compared to its trans counterpart due to steric hindrance effects.
Furthermore, environmental considerations have prompted researchers to investigate greener synthesis methods for this compound. Green chemistry principles are being applied to develop more sustainable routes that minimize waste and reduce energy consumption. These efforts are aligned with global initiatives to promote environmentally friendly chemical processes.
In conclusion,cis-1,2,3,4a-decahydro-naphthyridine is a versatile compound with a wide range of potential applications across multiple disciplines. Its unique structure makes it an ideal candidate for further research into drug development and materials science. As our understanding of this compound continues to grow thanks to cutting-edge research techniques like DFT modeling and green chemistry practices,the possibilities for innovation remain vast.
13623-83-1 (cis-1,2,3,4,4a,5,6,7,8,8a-decahydro-1,5-naphthyridine) Related Products
- 22990-77-8(2-Piperidinemethanamine)
- 120990-88-7(ethyl[(piperidin-2-yl)methyl]amine)
- 1235439-19-6(Isopropylpiperidin-3-ylamine)
- 531-67-9(2-(2-piperidyl)piperidine)
- 27643-19-2(methyl(piperidin-2-yl)methylamine)
- 1249848-14-3(N-Ethylpiperidin-3-amine)
- 111478-77-4((2S)-piperidin-2-ylmethanamine)
- 114366-16-4([(piperidin-2-yl)methyl](propan-2-yl)amine)
- 150395-92-9(N-methylpiperidin-3-amine)
- 933687-81-1(Decahydro-1,5-naphthyridine)